A. Bartoli

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study

Francesca Ferrua, Maria Pia Cicalese, Stefania Galimberti et al. · The Lancet Haematology · 2019 · 200 citations · Full text

A Multicenter Randomized Controlled Trial on the Clinical Impact of Therapeutic Drug Monitoring in Patients with Newly Diagnosed Epilepsy

Giuseppe Jannuzzi, P. Cian, Cinzia Fattore et al. · Epilepsia · 2000 · 138 citations

Neural Control of Heart Rate Is an Arrhythmia Risk Modifier in Long QT Syndrome

Peter J. Schwartz, Emilio Vanoli, Lia Crotti et al. · Journal of the American College of Cardiology · 2008 · 113 citations · Full text

Long Qt Syndrome, Heart Rate, Electrophysiological Evaluation +11

The Influence of Dosage, Age, and Comedication on Steady State Plasma Lamotrigine Concentrations in Epileptic Children

A. Bartoli, Renzo Guerrini, Anna Belmonte et al. · Therapeutic Drug Monitoring · 1997 · 84 citations

The pharmacokinetics of oxcarbazepine and its active metabolite 10‐hydroxy‐carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid

A Tártara, C. A. Galimberti, Raffaele Manni et al. · British Journal of Clinical Pharmacology · 1993 · 79 citations · Full text